Clinical Trial: A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity
Study Status: Completed
Recruit Status: RECRUITING
Condition: Sjogren's Syndrome
Study Type: INTERVENTIONAL
Official Title: A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome With Moderate-to-severe Systemic Disease Ac
Brief Summary:
Primary Objective:To evaluate the effect of dazodalibep on systemic manifestations of Sjögren's Syndrome (SS) in participants with moderate-to-severe systemic disease activity.Secondary Objectives:To evaluate the effect of dazodalibep on patient reported outcomes (PROs) in participants with SS.To evaluate the safety and tolerability of dazodalibep in participants with SS
Read more